A subscription to JoVE is required to view this content. Sign in or start your free trial.
Here, we present a method to differentiate and expand human iPSC-derived chimeric antigen receptor (CAR)-expressing natural killer cells with improved killing against various malignancies. This protocol demonstrates the differentiation and expansion of natural killer (NK) optimized iPSC-derived CAR-NK cells and the measurement of antitumor activity against various tumor cell lines.
Natural killer (NK) cells are innate immune cells that play a crucial role in the body's defense against tumors and viral infections. The generation of human induced pluripotent stem cell (iPSC)-derived chimeric antigen receptor (CAR) expressing NK cells has emerged as a promising avenue for "off the shelf" cancer immunotherapy. Here, we utilized an NK cell-optimized CAR construct that includes the transmembrane domain of NKG2D, the 2B4 co-stimulatory domain, and the CD3ζ signaling domain, which has been demonstrated to stimulate robust antigen-specific NK cell-mediated antitumor activity. The use of iPSCs for CAR NK cell generation offers several advantages, including homogenous CAR expression, scalability, reproducibility, and the potential for clinical application. This detailed step-by-step protocol from cell engineering to differentiation enables the generation of NK cell-optimized iPSC-derived CAR-expressing NK cells, providing a standardized and targeted cancer immunotherapy with improved antitumor activity and highlighting their potential as a promising treatment option for various malignancies.
NK cells, a type of lymphocyte within the innate immune system, are pivotal in the early defense against tumors and virally infected cells1,2,3. Unlike T cells, NK cells do not require antigen presentation via major histocompatibility complex (MHC) molecules. Instead, NK cells have a repertoire of activating and inhibitory receptors that regulate their activity3. NK cell-mediated cytotoxic activity utilizes various mechanisms, including the release of perforin and granzymes, engagement of death receptors, and the production of pro-inflammatory cytokine....
1. Feeder-free culture method of human iPSCs
NOTE: Thaw the frozen undifferentiated human iPSCs and culture them with the use of mTeSR 1-plus on Matrigel (henceforth referred to as basement membrane matrix [BMM]) pre-coated plates, as previously described23,34. It is very important to make sure the iPSCs are not differentiated before and after engineering. Freshly thawed iPSCs should be cultured for about 2-3 passages to exhibit pluripotency morphology consistent with the human pluripotent stem cells. The following instructions are used for passaging cells from one we....
Schematic diagram of anti-GPC3-CAR iPSC derived NK cells differentiation and expansion
The schematic diagram illustrates the in vitro differentiation of anti-GPC3-CAR engineered NK cells derived from human induced pluripotent stem cells (iPSCs) and a schematic representation of piggyBac vector carrying GPC3 CAR construct. Initially, unmodified iPSCs are transfected with a piggyBac vector encoding the GPC3 CAR (chimeric antigen receptor). Following transfection, these GPC3 CAR-expressing iP.......
This protocol outlines a standardized and reproducible approach for generating CAR-expressing, iPSC-derived NK cells from a consistent cell source aimed at facilitating targeted "off-the-shelf" cancer immunotherapy. Multiple preclinical and clinical studies have shown the efficacy of adoptive NK cell-based immunotherapy in treating cancers while minimizing toxicities, like graft versus host diseases (GvHD) or cytokine-release syndrome (CRS)23,42,
DSK is a co-founder and advisor to Shoreline Biosciences and has an equity interest in the company. DSK also consults for Therabest and RedC Bio for which he receives income and/or equity. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict-of-interest policies. The remaining authors declare no competing interests.
We thank all Kaufman lab members for their support, scientific insights and discussions. These studies were supported by the NIH/NCI grants U01CA217885, P30CA023100 (administrative supplement) and the Sanford Stem Cell Institute at UCSD. JT: writing and revision of manuscript. DSK: reviewed and edited the manuscript.
....Name | Company | Catalog Number | Comments |
aAPC | Dean A. Lee lab | N/A | |
a-MEM culture medium | Fisher Scientific | Cat#12634 | |
APC anti-DYKDDDDK (FLAG Tag) | BD Biosciences | Cat#637308 | |
APC-anti-human TRA-1-81 | ThermoFisher | 17-8883-42 | |
APC-CD16 | BD Biosciences | Cat#302015 | |
APC-CD43 | BD Biosciences | Cat# 560198 | |
APC-CD45 | BD Biosciences | Cat# 555485 | |
APC-GPC3 | BD Biosciences | Cat#DB100B | |
APC-NKG2D | BD Biosciences | Cat# 558071 | |
CellEvent Caspase-3/7 Green Detection Reagent | Thermo fisher | Cat#C10423 | |
CellTrace Violet Cell Proliferation Kit | Thermo fisher | Cat#C34571 | Cell tracing fluorescent dye |
CryoStor solution | Stem Cell Technologies | https://www.stemcell.com/products/cryostor-cs10.html | Cryopreservation medium |
CTS NK Xpander | Gibco | A5019001 | |
CTS NK-Xpander Medium | Life Technologies | Cat#A5019001 | |
DMEM | Gibco | 11965084 | |
DMEM, high glucose, GlutaMAX Supplement, pyruvate | Gibco | 10569010 | |
EasySep Human NK Cell Enrichment Kit | StemCell Technologies, Inc. | Cat#19055 | |
Ethanolamine | Sigma Aldrich | E9508 | |
Fetal bovine serum | Fisher Scientific | Cat# 10437010 | |
FITC-CD94 | BD Biosciences | Cat#555888 | |
GlutaMAX Supplement | Gibco | 35050061 | |
GolgiPlug | BD Biosciences | Cat#555029 | |
GolgiStop | BD Biosciences | Cat#554724 | |
Ham's F-12 Nutrient Mix, GlutaMAX Supplement | Gibco | 31765035 | |
Horse serum | Fisher Scientific | Cat#16050130 | |
Human Serum | AB Sigma-Aldrich | Cat#BP2525100 | |
Human Stem Cell NucleofectorTM Kit | Lonza | Cat# VPH-5012 | |
Human: HePG2 cells | ATCC | Cat#HB-8065 | |
Human: HePG2-td-tomato-luc cells | Dan S. Kaufman lab | N/A | |
Human: iPS cells | Dan S. Kaufman lab | N/A | |
Human: SNU-449 cells | ATCC | Cat#CRL-2234 | |
Human: SNU-449-td-tomato-luc cells | Dan S. Kaufman lab | N/A | |
IncuCyte Caspase-3/7 Green Apoptosis Assay | Essenbioscience | Cat#4440 | |
L-Ascorbic acid | Sigma Aldrich | A5960 | |
MP Biomedicals Human Serum, Type AB | MP Biomedicals | ICN2938249 | |
mTeSR plus | StemCell Technologies, Inc. | 100-0276 | |
NovoExpress software | ACEA Biosciences | https://www.agilent.com/en/product/research-flow-cytometry/flow-cytometry-software/novocyte-novoexpress-software-1320805 | |
PE/Cy7 anti-human SSEA-4 Antibody | Biolegend | 330420 | |
PE-CD16 | BD Biosciences | Cat#560995 | |
PE-CD226 | BD Biosciences | Cat#559789 | |
PE-CD34 | BD Biosciences | Cat# 555822 | |
PE-CD45 | BD Biosciences | Cat# 555483 | |
PE-CD94 | BD Biosciences | Cat#555888 | |
PE-cy7-CD56 | BioLegend | Cat# 318318 | |
PE-FAS Ligand | BD Biosciences | Cat#564261 | |
PE-NKp30 | BD Biosciences | Cat# 558407 | |
PE-NKp44 | BD Biosciences | Cat#558563 | |
PE-NKp46 | BD Biosciences | Cat#331908 | |
PE-NKp46 | BD Biosciences | Cat#557991 | |
Peripheral blood buffy coat | San Diego Blood Bank (https://www. sandiegobloodbank.org/) | N/A | |
PE-TRAIL | BD Biosciences | Cat#565499 | |
pKT2-mCAG-IRES-GFP-ZEO | Branden Moriarity lab | N/A | |
pMAX-GFP plasmid | Lonza | N/A | GFP positive control |
Prism 9 | Graphpad | Version 9 | |
pSpCas9 | GenScript | PX165 | |
RBC Lysis Buffer (10x) | Biolegend | Cat#420301 | |
Recombinant human bFGF basic | R&D Systems | Cat#4114-TC | |
Recombinant human BMP-4 | PeproTech | Cat#120-05 | |
Recombinant human FLT-3 Ligand | PeproTech | Cat# 300-19 | |
Recombinant human IL-15 | PeproTech | Cat# 200-15 | |
Recombinant human IL-2 | PeproTech | Cat# 200-02 | |
Recombinant human IL-3 | PeproTech | Cat#200-03 | |
Recombinant human IL-7 | PeproTech | Cat# 200-07 | |
Recombinant Human Nodal Protein | R&D Systems | Cat#3218-ND-025 | |
Recombinant human SCF | PeproTech | Cat# 300-07 | |
Recombinant Human TGF-β1 | PeproTech | Cat#100-21 | |
Recombinant human VEGF | PeproTech | Cat# 100-20 | |
RPMI1640 | Gibco | 11875093 | |
Sodium selenite | Sigma Aldrich | 214485 | |
STEMdiff APEL 2 Medium | StemCell Technologies, Inc. | 5270 | EB formation medium |
STEMdiff APEL2 Medium | StemCell Technologies, Inc. | Cat#05270 | |
Super piggyBac Transposase expression vector | SBI | Cat#PB210PA-1 | |
SYTOX AADvanced Dead Cell Stain Kit | ThermoFisher Scientific | S10274, S10349 | Dead cell staining solution kit |
β-mercaptoethanol | Gibco | 21985023 |
Request permission to reuse the text or figures of this JoVE article
Request PermissionExplore More Articles
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved